Holen Sie sich die Stockscreener-App
4.20
4.55%
-0.20
Schlusskurs vom Vortag:
$4.40
Offen:
$4.33
24-Stunden-Volumen:
344.09K
Relative Volume:
0.32
Marktkapitalisierung:
$378.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.31M
KGV:
-3.3071
EPS:
-1.27
Netto-Cashflow:
$-62.80M
1W Leistung:
-5.19%
1M Leistung:
+14.44%
6M Leistung:
-8.50%
1J Leistung:
-18.60%
1-Tages-Spanne:
$4.20
$4.39
1-Wochen-Bereich:
$4.19
$4.56
52-Wochen-Spanne:
$2.215
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Vergleichen Sie RZLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
4.20 | 378.85M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Rezolute’s SWOT analysis: ersodetug trials boost stock amid clinical milestones - Investing.com India
Bank of America Corp DE Has $443,000 Stock Position in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Two Sigma Investments LP Sells 12,118 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Squarepoint Ops LLC Sells 3,980 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Millennium Management LLC Decreases Stake in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
69,724 Shares in Rezolute, Inc. (NASDAQ:RZLT) Bought by Ameriprise Financial Inc. - Defense World
Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77% - Yahoo Finance
BTIG maintains $15 target on Rezolute stock following trial update - Investing.com Australia
BTIG maintains $15 target on Rezolute stock following trial update By Investing.com - Investing.com India
Rezolute Announces Completion Of Enrollment In The Phase 3 Sunrize Study Of Ersodetug In Patients With Congenital Hyperinsulinism - marketscreener.com
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug - TipRanks
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | - GuruFocus
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | RZLT Stock News - GuruFocus
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism - The Manila Times
Man Group plc Makes New $425,000 Investment in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - The Globe and Mail
13 Best Multibagger Stocks to Invest in Now - Insider Monkey
Rezolute, Inc. (RZLT): Analysts See 260% Upside Potential - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Rezolute Inc (NASDAQ: RZLT) Is The Hottest Stock Right Now. - Stocksregister
Balyasny Asset Management L.P. Purchases New Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
HC Wainwright Analysts Lift Earnings Estimates for Rezolute - Defense World
Wedbush Forecasts Rezolute’s FY2025 Earnings (NASDAQ:RZLT) - Defense World
Rezolute (NASDAQ:RZLT) Earns Outperform Rating from Wedbush - Defense World
Rezolute (RZLT) Advances Studies on Hyperinsulinism Treatments | - GuruFocus
Rezolute (RZLT) to Release Earnings on Wednesday - Defense World
Rezolute Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Rezolute (RZLT) Advances Studies on Hyperinsulinism Treatments | RZLT Stock News - GuruFocus
Rezolute, Inc. Reports Progress on sunRIZE Enrollment and Breakthrough Therapy Designation for Ersodetug in Hypoglycemia Treatment - Nasdaq
Rezolute Secures FDA Breakthrough Status as Phase 3 Trial Nears Full Enrollment - Stock Titan
Barclays PLC Takes Position in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com
Rezolute Gets US FDA Breakthrough Therapy Designation for Hypoglycemia Treatment - marketscreener.com
Rezolute (RZLT) Gains FDA Breakthrough Status for Hypoglycemia T - GuruFocus
FDA grants breakthrough status to Rezolute’s hypoglycemia therapy - Investing.com
FDA grants breakthrough status to Rezolute’s hypoglycemia therapy By Investing.com - Investing.com India
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism - The Manila Times
FDA Breakthrough: New Drug Shows Promise Against Life-Threatening Tumor-Induced Hypoglycemia - Stock Titan
Renaissance Technologies LLC Reduces Stake in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Inc (RZLT) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Finance Watch: Biohaven Gains Up To $600m In Fresh Capital - insights.citeline.com
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Rezolute: RZ402 Could Be A Surprise Candidate In The Making (NASDAQ:RZLT) - Seeking Alpha
Wedbush gives an Outperform recommendation for Rezolute Inc (RZLT) - knoxdaily.com
Market Recap: Rezolute Inc (RZLT)’s Positive Momentum, Closing at 3.86 - DWinneX
Rezolute’s $90 Million Common Stock Offering - Global Legal Chronicle
Rezolute (NASDAQ:RZLT) Given Buy Rating at HC Wainwright - Defense World
Geode Capital Management LLC Has $2.54 Million Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Closes $96.9 Million Underwritten Offering - TipRanks
Rezolute (RZLT) SunRIZE Trial Progresses Without Changes | RZLT Stock News - GuruFocus
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):